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The type I interferon response is an important innate antiviral pathway. Recognition of viral
RNA by RIG-I-like receptors (RLRs) activates a signaling cascade that leads to type I inter-
feron (IFN-α/β) gene transcription. Multiple proteins in this signaling pathway (e.g. RIG-I,
MDA5, MAVS, TBK1, IRF3) are regulated by (de)ubiquitination events. Most viruses have
evolved mechanisms to counter this antiviral response. The leader protease (Lpro) of foot-
and-mouth-disease virus (FMDV) has been recognized to reduce IFN-α/β gene transcrip-
tion; however, the exact mechanism is unknown. The proteolytic activity of Lpro is vital for
releasing itself from the viral polyprotein and for cleaving and degrading specific host cell
proteins, such as eIF4G and NF-κB. In addition, Lpro has been demonstrated to have deubi-
quitination/deISGylation activity. Lpro’s deubiquitination/deISGylation activity and the cleav-
age/degradation of signaling proteins have both been postulated to be important for
reduced IFN-α/β gene transcription. Here, we demonstrate that TBK1, the kinase that phos-
phorylates and activates the transcription factor IRF3, is cleaved by Lpro in FMDV-infected
cells as well as in cells infected with a recombinant EMCV expressing Lpro. In vitro cleavage
experiments revealed that Lpro cleaves TBK1 at residues 692–694. We also observed cleav-
age of MAVS in HeLa cells infected with EMCV-Lpro, but only observed decreasing levels of
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MAVS in FMDV-infected porcine LFPK αVβ6 cells. We set out to dissect Lpro’s ability to
cleave RLR signaling proteins from its deubiquitination/deISGylation activity to determine
their relative contributions to the reduction of IFN-α/β gene transcription. The introduction of
specific mutations, of which several were based on the recently published structure of Lpro in
complex with ISG15, allowed us to identify specific amino acid substitutions that separate
the different proteolytic activities of Lpro. Characterization of the effects of these mutations
revealed that Lpro’s ability to cleave RLR signaling proteins but not its deubiquitination/deIS-
Gylation activity correlates with the reduced IFN-β gene transcription.
Author summary
Outbreaks of the picornavirus foot-and-mouth disease virus (FMDV) have significant
consequences for animal health and product safety and place a major economic burden
on the global livestock industry. Understanding how this notorious animal pathogen sup-
presses the antiviral type I interferon (IFN-α/β) response may help to develop counter-
measures to control FMDV infections. FMDV suppresses the IFN-α/β response through
the activity of its Leader protein (Lpro), a protease that can cleave host cell proteins. Lpro
was also shown to have deubiquitinase and deISGylase activity, raising the possibility that
Lpro suppresses IFN-α/β by removing ubiquitin and/or ISG15, two posttranslational mod-
ifications that can regulate the activation, interactions and localization of (signaling) pro-
teins. Here, we show that TBK1 and MAVS, two signaling proteins that are important for
activation of IFN-α/β gene transcription, are cleaved by Lpro. By generating Lpro mutants
lacking either of these two activities, we demonstrate that Lpro’s ability to cleave signaling
proteins, but not its deubiquitination/deISGylase activity, correlates with suppression of
IFN-β gene transcription.
Introduction
A virally infected cell activates a plethora of antiviral responses. One of the best-known antivi-
ral responses is the induction of type I interferons (IFN-α/β). Replication of the viral genome
generates double-stranded RNA (dsRNA) replication intermediates that can be recognized by
cytoplasmic RIG-I like receptors (RLRs). For example, picornaviruses, small (~30 nm) non-
enveloped viruses with a positive-sense RNA genome, synthesize replication intermediates
that are predominantly recognized by MDA5 [1–4]. Upon recognition of viral dsRNA, MDA5
interacts with MAVS, which subsequently activates TRAF3 and TBK1. TBK1 phosphorylates
the transcription factors IRF3 and IRF7, resulting in their activation and dimerization. Simul-
taneously, TRAF3 interacts with the IKK complex to activate the transcription factor NF-κB.
Upon activation, IRF3, IRF7 and NF-κB translocate to the nucleus, where they induce expres-
sion of IFN-α/β and other proinflammatory cytokines. Subsequent IFN-α/β signaling via the
type I IFN receptor (IFNAR) and the JAK-STAT pathway induces the expression of hundreds
of interferon stimulated genes (ISGs) (reviewed in [5,6]).
IFN-α/β gene transcription is extensively regulated by post-translational modification of
RLRs and their downstream signaling proteins, including phosphorylation and ubiquitination.
Ubiquitin is a 8.5 kDa protein that can be covalently linked through an ε-amino peptide link-
age to lysine residues in target proteins. Within the RLR signaling pathway RIG-I, MAVS,
TBK1, TRAF3, TRAF6 and IKKγ are ubiquitinated and this affects their molecular
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interactions, localization, stability, or activity (reviewed in [7,8]). Ubiquitination of RLR sig-
naling proteins can both positively and negatively regulate the signaling pathway, which allows
for rapid fine-tuning of the innate immune response against viral infection (reviewed in [7–
9]). Consequently, many viruses encode enzymes with deubiquitinating (DUB) activity to
manipulate the RLR signaling pathway and thereby suppress expression of IFN-α/β (reviewed
in [9]).
In addition to ubiquitin, there are multiple ubiquitin-like modifiers, which can also be
attached to target proteins. Of special interest is ISG15, an IFN-induced modifier of 17.5 kDa
comprised of two ubiquitin-like domains in tandem. The exact antiviral properties of ISG15
are not yet fully understood (reviewed in [10,11]). Early work on ISG15 depended on mouse
models and showed that expression of ISG15 protected mice from viral infection [12–15].
However, important biological and structural differences between ISG15 of murine and
human origin have since been reported [16–19]. More recently, a picture is emerging that pro-
teins are ISGylated co-translationally, explaining why predominantly viral proteins and ISGs
are ISGylated upon infection in humans [20]. ISGylation of RLR signaling proteins has been
reported, but the effect of these modifications on the outcome of the signaling pathway is still
unclear ([21–24], reviewed in [11]). In addition, ISG15 has been reported to act as a cytokine
[25,26].
IFN-α/β signals in autocrine and paracrine ways to induce a tissue-wide antiviral state,
thereby limiting viral spread. To establish infection in their host, it is essential for viruses to
suppress both the RLR signaling pathway and the downstream signaling of IFN-α/β. Affecting
protein levels of important signaling molecules, either via cleaving them or inducing their deg-
radation, is a strategy commonly used by viruses to suppress antiviral signaling [27–30]. One
such example is the picornavirus foot-and-mouth disease virus (FMDV). FMDV is a member
of the genus Aphthovirus, which also contains bovine rhinitis A and B viruses, and equine rhi-
nitis A virus (ERAV). The genetic information on the FMDV RNA genome is translated as
one polyprotein that is autocatalytically processed into the mature proteins, two of which have
been shown to possess proteolytic activity and also been implicated in suppressing IFN-α/β
induction (reviewed in [31]). The 3Cpro, the protease that processes the majority of cleavage
sites on the polyprotein, cleaves NF-κB essential modulator (NEMO), an adaptor protein that
is essential to activate the NFκB and IRF signaling pathways [32].
The second protease on the polyprotein implicated in suppressing IFN-α/β induction is
Lpro, a papain-like cysteine protease located at the N-terminus of the polyprotein [33]. Once
synthesized, Lpro immediately frees itself from the growing peptide chain by autocleavage at its
own C-terminus. Lpro then efficiently cleaves the two isoforms of eIF (eukaryotic initiation fac-
tor) 4G to reduce protein synthesis from cellular mRNA [34] and suppresses the induction of
IFN-α/β via several mechanisms. Lpro has been shown to induce the degradation of NF-κB
subunit p65/RelA [35,36], and decrease the levels of IFN regulatory factor 3 (IRF3) and IRF7
[37]. Further, Lpro can also interact with ADNP, a negative regulator of transcription [38]. In
addition to cleaving or degrading important signaling molecules, Lpro possesses deubiquitinase
(DUB) activity which has been proposed to modulate RLR signaling [39]. A subsequent study
demonstrated that Lpro should be predominantly regarded as a deISGylase rather than a DUB
as biochemical evidence showed that Lpro has a 1000-fold higher affinity for ISG15 than for
ubiquitin [40]. Structural studies and biochemical studies have shown separate substrate bind-
ing sites on Lpro for the viral polyprotein, the isoforms of eIF4G as well as for ubiquitin and
ISG15 [40–42], suggesting that it may be possible to uncouple the activities of Lpro by the intro-
duction of specific amino acid substitutions.
We therefore set out to uncouple the different activities of Lpro to discover whether Lpro
suppresses RLR signaling through its deISGylase/DUB activity or through its ability to cleave
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and degrade multiple RLR signaling proteins. In this work, utilizing encephalomyocarditis
virus (EMCV) expressing FMDV Lpro (EMCV-Lpro), we identified MAVS and TBK1 as new
Lpro substrates and determined the cleavage site in TBK1. By introducing specifically designed
mutations into Lpro, we further identified residues that are important for either the cleavage/
degradation of RLR signaling proteins or for its deISGylase/DUB activity, thereby uncoupling
the two catalytic activities of Lpro. We demonstrate that cleavage/degradation of RLR signaling
proteins, but not the deISGylase/DUB activity of Lpro, correlates with suppressing IFN-α/β
gene transcription.
Results
FMDV Lpro reduces IFN-β mRNA induction when introduced into a
recombinant EMCV containing an inactive stress antagonist
To study the effects of Lpro on the induction of type I IFN in picornavirus-infected cells, we
used two previously generated recombinant viruses; EMCV-LZn, which contains inactivating
mutations in the zinc-finger domain of the Leader (i.e. EMCV’s RLR signaling antagonist)
[1,43,44], and EMCV-Lpro, which was derived from EMCV-LZn and additionally encodes
FMDV Lpro at the N-terminus of its polyprotein (Fig 1A) [45]. We also constructed a similar
Fig 1. Lpro reduces IFN-β gene transcription when introduced into a recombinant EMCV containing an inactive
stress antagonist. (A) Schematic representation of the recombinant EMCV-LZn and EMCV-Lpro viruses (the latter was
described in detail in [45]). In EMCV-LZn, L contains inactivating mutations in its Zn-finger domain (C19A/C22A)
which abolishes its ability to suppress antiviral responses. To generate EMCV-Lpro, the Lbpro gene of FMDV O-strain
was introduced at the 5’ end of the EMCV-LZn open reading frame. The Lpro cleavage site at its own C-terminus was
mutated to AAA. Instead Lpro is released from this viral polyprotein via an EMCV 3C cleavage site. (B) Hela R19 cells
were infected at MOI 10 with the indicated viruses and cells were lysed at 2,4,6,8 h pi. Total RNA was isolated and used
for RT-qPCR analysis for IFN-β and actin mRNA, and EMCV vRNA. The IFN-β levels are depicted as a fold induction
compared to levels in mock-infected cells, after correction for actin mRNA levels. The EMCV vRNA is depicted as a
copy number per cell, calculated from a plasmid standard. Error bars depict the SD. One-way ANOVA with the Dunnet
post hoc test was used to determine statistical significance compared to the results for EMCV-LZn-infected cells (�,
p<0.05; ���, p<0.001; ����, p<0.0001; ns, no significant difference).
https://doi.org/10.1371/journal.ppat.1008702.g001
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recombinant EMCV carrying a catalytically inactive Lpro (i.e. EMCV-Lpro C51A) [46]. To deter-
mine whether EMCV-Lpro can suppress IFN-β induction, we infected HeLa cells with EMCV,
EMCV-LZn, EMCV-Lpro or EMCV-Lpro C51A and determined the IFN-β mRNA levels over
time via RT-qPCR analysis (Fig 1B). Consistent with previous studies [37,39,47], wt Lpro, but
not Lpro C51A, reduced the induction of IFN-β mRNA approximately 10-fold, indicating that
the catalytic activity of Lpro is needed to suppress RLR signaling. In conclusion, the viruses that
we generated (EMCV-Lpro and EMCV-Lpro C51A) accurately mimic the suppression of RLR
signaling by Lpro as previously reported for FMDV-infected cells [47], providing us a model sys-
tem to determine the mechanism via which Lpro suppresses type I IFN induction.
Lpro cleaves the RLR signaling proteins MAVS and TBK1
Lpro has been reported to degrade important signaling proteins such as the p65 subunit of NF-
κB, IRF3 and IRF7 [35,37]. To determine whether Lpro targets additional RLR signaling pro-
teins, we subjected cell lysates of HeLa cells infected with EMCV-LZn, EMCV-Lpro or
EMCV-Lpro C51A to Western Blot analysis for the signaling proteins MAVS, TBK1 and IRF3,
as well as the known Lpro-substrates eIF4G and G3BP1 (Fig 2A). EMCV capsid proteins and
tubulin served as infection and loading controls, respectively. Infection with EMCV-Lpro, but
not EMCV-Lpro C51A, resulted in the rapid cleavage of eIF4G (from 4 hpi onwards) and the
cleavage of G3BP1 (from 6 hpi onwards). We did not observe cleavage or degradation of IRF3
as was suggested by others [37]. In addition to these known cleavages, we observed cleavage of
MAVS and TBK1 at 8 hpi. For MAVS, we observed multiple cleavage products ranging in
apparent molecular weight from ~45 kDa to ~35 kDa. TBK1 cleavage resulted in a single cleav-
age product with an apparent molecular weight of ~90–95 kDa. We also attempted to detect
MDA5 and investigate whether this dsRNA sensor is targeted by Lpro. Unfortunately, the low
levels of MDA5 prevented us from detecting the endogenous protein. MDA5 expression could
be boosted by pretreatment with recombinant IFN-α2, but IFN-α2 pretreatment inhibited effi-
cient EMCV infection, thereby interfering with the subsequent analysis.
We next focused our attention to identifying the cleavage site in TBK1. To this end, we over-
expressed N-terminally FLAG-tagged TBK1 together with GFP-tagged Lpro and performed
Western Blot analysis. As seen in Fig 2B, GFP-Lpro was able to cleave FLAG-TBK1. We observed
an αFLAG-reactive cleavage product migrating at ~90–95 kDa, the same apparent molecular
weight as the cleavage product we observed in EMCV-Lpro infected cells (Fig 2A), suggesting
that Lpro cleaves TBK1 at its C-terminus. We also co-incubated recombinant His-TBK1 with
increasing amounts of recombinantly expressed Lpro and Lpro C51A (Fig 2C). The in vitro incu-
bation of His-TBK1 with wt Lpro also resulted in a ~90–95 kDa αHis-reactive cleavage product,
confirming that Lpro cleaves TBK1 at its C-terminus and does not rely on other cellular factors.
Incubation of His-TBK1 with catalytically inactive Lpro did not result in the formation of a
cleavage product, confirming that the cleavage is dependent on Lpro’s proteolytic activity. Subse-
quently, we showed that Lpro also cleaves TBK1 of murine origin (Fig 2D), which suggests that
Lpro cleaves TBK1 in a conserved region. We identified residues 692KLK694 –which localize at
the very C-terminus of TBK1 and are well conserved between human, murine and porcine
TBK1 –as a possible cleavage site (Fig 2E). Indeed, mutation of these residues prevented the
cleavage of TBK1 by Lpro (Fig 2D), confirming these residues are the cleavage site.
Upon identifying the cleavage site in TBK1, we next investigated whether the cleavage of
TBK1 by Lpro inhibits its function in the RLR signaling pathway. To this end, we generated
cells in which the endogenous TBK1 gene is replaced with a TBK1 truncation mutant repre-
sentative of the ~90–95 kDa cleavage product. We first generated HeLa TBK1 k.o. cells using
CRISPR/cas9 technology and characterized the remaining RLR signaling capacity of these cells
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Fig 2. Lpro cleaves MAVS and TBK1. (A) HeLa R19 cells were infected at MOI 10 with the indicated viruses and lysed
at 2,4,6,8 h pi. Cell lysates were subjected to Western Blot analysis for MAVS, TBK1, IRF3, eIF4GI, G3BP1, EMCV
capsid proteins and tubulin. (B) HEK293T cells were transfected with 1 μg pcDNA-FLAG-TBK1 plasmid and 0.5 μg
pIRES-GFP-Lpro plasmid. 16 h post transfection cells were lysed and lysates were subjected to Western Blot analysis for
FLAG and GFP. (C) His-hTBK1 was incubated with 0–3 μg sLpro or 3 μg sLpro C51A for 2 h and reaction mixtures
were subsequently subjected to Western Blot analysis for His. (D) HeLa OHIO cells were transfected with 7 μg pCS2-
6Myc-mTBK1 or pCS2-6Myc-mTBK1692AAA694. 24 h post transfection, cells were lysed and incubated with 2 μg
recombinant sLpro for 2 h before being subjected to Western Blot analysis for HA. (E) Comparison of TBK1 amino
acids 661–729 of human and mouse origin. Asterisks denote conserved residues. KLK at position 692–694 was
mutated to AAA.
https://doi.org/10.1371/journal.ppat.1008702.g002
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(S1A and S1B Fig). We found that depletion of TBK1 is not sufficient to fully impair RLR sig-
naling, probably because of functional redundancy with IKKε (S1B Fig). TBK1 k.o. cells have a
~10-fold lower IFN-β induction upon infection with EMCV-LZn, transfection of vRNA or
upon overexpression of MAVS. As expected, IFN-β induction resulting from transfection of
IRF3, which acts downstream of TBK1, was not affected in the TBK1 k.o. cells. Subsequently,
we expressed full length TBK1 or TBK1 Δ35aa, which represents the N-terminal cleavage prod-
uct, in TBK1 k.o. cells (S1C Fig) and determined whether expression of TBK1 and TBK1
Δ35aa restored IFN-β mRNA expression upon transfection of poly (I:C). Expression of full
length TBK1 in TBK1 k.o. cells fully restored IFN-β mRNA induction (S1D Fig) and TBK1
Δ35aa was similarly efficient in this (S1E Fig), indicating that the Lpro-generated N-terminal
cleavage product is signaling competent.
TBK1 is cleaved during aphthovirus infection
To investigate whether TBK1, MAVS and IRF3 are cleaved during FMDV infection, we infected
porcine LFPK αvβ6 cells with wt FMDV-A12 or FMDV-A12 lacking Lpro (leaderless virus,
A12-LLV). Western Blot analysis revealed cleavage of TBK1, but not of MAVS or IRF3, during
wt FMDV-A12 infection (Fig 3A). TBK1 cleavage was observed from 4 hpi onwards upon infec-
tion with wt FMDV, but not upon infection with leaderless FMDV. The cleavage product had
an apparent molecular weight of ~90–95 kDa, consistent with our previous observations of the
size of this cleavage product. Although a MAVS cleavage product was not detected during
FMDV infection, densitometry analysis revealed a strong and progressive decrease in the rela-
tive ratio of MAVS/tubulin from 2–6 hpi post infection with wt FMDV compared to mock-
infected cells, whereas only a small decrease was detected in leaderless-infected cells (MAVS/
tubulin ratio is indicated in Fig 3A). This suggests that expression of Lpro induces degradation
of MAVS, also in FMDV-infected cells. Consistent with our observations in EMCV-Lpro
infected cells, we did not observe a decrease in IRF3 signal in FMDV-infected cells.
To investigate whether the cleavage of TBK1 is conserved amongst aphthoviruses, we
infected cells with ERAV, the closest relative of FMDV. Infection with ERAV, but not EMCV,
resulted in the cleavage of TBK1 (Fig 3B). However, the cleavage product was less prominent
than for EMCV-Lpro, suggesting that cleavage was inefficient or infection was delayed. Nota-
bly, in our HeLa cells, ERAV displayed a replicative cycle of ~16 h. This is considerably slower
than FMDV, which replicates in 6–8 hours. To study TBK1 cleavage by the two different Lpro’s
irrespective of variation in viral replication kinetics, we infected cells with EMCV-Lpro or an
EMCV expressing ERAV Lpro (EMCV-ERAV Lpro), for which we previously determined the
replication kinetics to be similar [45]. Both viral proteases cleaved TBK1 resulting in a ~90–95
kDa cleavage product (Fig 3C). FMDV Lpro cleaved TBK1 more efficiently than ERAV Lpro,
consistent with the results observed during infection with FMDV or ERAV (Fig 3A and 3B).
Notwithstanding the differences between ERAV Lpro and FMDV Lpro, our data demonstrate
that the ability to cleave TBK1 is conserved amongst these two aphthoviruses.
We also investigated the effect of the pan-caspase inhibitor Q-VD-PH (Q-VD) on TBK1 cleav-
age in ERAV-infected cells (Fig 3D). While addition of Q-VD decreased the cleavage of known
caspase substrate PARP, the cleavage of TBK1 was unaffected. Collectively, these results demon-
strate that Lpro directly cleaves TBK1 and that this activity is conserved amongst aphthoviruses.
Construction of Lpro mutants to uncouple cleavage/degradation of RLR
signaling proteins from its deISGylase/DUB activity
Lpro also possesses deISGylase and—to a lesser extent—DUB activity [39,40,42], and this latter
activity was previously suggested to be important for Lpro’s ability to suppress RLR signaling
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[39]. To investigate how Lpro reduces the induction of IFN-β gene transcription, we set out to
uncouple these two abilities of Lpro. To this end, we introduced previously described mutations
in the chimeric EMCV-Lpro and determined whether these mutations affect the deISGylase/
DUB activity of Lpro and/or its ability to cleave/degrade RLR signaling proteins. A mutation in
the SAP domain (I83A/L86A), was previously reported to abolish the ability of Lpro to suppress
type I IFN expression, to degrade signaling proteins (i.e. NF-κB p65, IRF3 and IRF7), and to
disrupt its DUB activity [36,37,39], and was therefore included in our screening. Analysis of
the crystal structure of Lpro bound to ISG15 suggested that Lpro residues L92, P99 and L102 are
important for ISG15 binding [40]. Fig 4A shows the structure of Lpro (grey) in complex with
ISG15 (blue) and indicates the residues of ISG15 (W123 and R153, L154, G155) that interact
with Lpro. Mutation of L92, P99 or L102 in Lpro reduced its affinity for ISG15 and impaired its
deISGylase activity, without affecting eIF4G cleavage [40]. Homology modeling showed that
ISG15 and ubiquitin interact with the same surfaces of Lpro [40], suggesting that Lpro’s deISGy-
lase activity also reflects its DUB activity. Two of these mutations (L92A and L102A) were
introduced in EMCV-Lpro. In addition, we introduced the mutations L143A and C133S. Muta-
tion C133S was reported to reduce the affinity of Lpro for eIF4G [48] whereas mutation of to
L143 to alanine with its shorter side-chain rescued polyprotein processing in the context of the
additional mutation L200F [49]. Based on the structure of Lpro, mutation L143A has been pre-
dicted to open up the catalytic pocket. Fig 4 shows the locations of the residues that are
mutated in this study (Fig 4A) and summarizes the reported effects of these mutations on
Lpro’s various proteolytic activities (Fig 4B).
Effect of Lpro mutations on cleavage and/or degradation of RLR signaling
proteins
First, we determined the effect of the introduced mutations on Lpro’s ability to cleave or
degrade RLR signaling proteins. We infected Hela cells with EMCV, EMCV-LZn or the differ-
ent EMCV-Lpro carrying the described mutations, lysed the cells at the indicated timepoints
and subjected the lysates to Western Blot analysis for MAVS, TBK1, NF-κB subunit p65, IRF3,
eIF4G and G3BP1, as well as Lpro and EMCV capsid proteins (Fig 5). Our data show that infec-
tion with the different Lpro mutant viruses resulted in Lpro expression and accumulation of
EMCV capsid proteins from 6 hpi onwards, which is indicative of efficient infection. Interest-
ingly, the introduced mutations in Lpro had different effects on the cleavage or degradation of
RLR signaling proteins. Upon infection with EMCV-Lpro C133S, we observed a ~2 hr delay in
eIF4G cleavage, consistent with a previous report [48]. This mutation did not affect the cleav-
age/degradation of the various RLR signaling proteins. Mutation of L92 or L102 has been
reported to reduce the activity of Lpro towards ISG15, without affecting eIF4G cleavage [40].
Indeed, infection with EMCV-Lpro L92A, resulted in cleavage of eIF4G, as well as all other Lpro
substrates (i.e. MAVS, TBK1, NF-κB p65 and G3BP1) (Fig 5). Infection with both EMCV-Lpro
L92A and EMCV-Lpro L102A resulted in efficient cleavage of RLR signaling proteins, confirm-
ing that these two Lpro mutants have the same proteolytic profiles (Fig 6). Of note, the cleavage
Fig 3. TBK1 is cleaved in aphthovirus infected cells. (A) LFPK αvβ6 cells were infected with FMDV-A12 or
leaderless FMDV-A12 (LLV) at MOI 10 and lysed at the indicated times postinfection. Lysates were subjected to
Western blot analysis for MAVS, TBK1, IRF3, eIF4G, G3BP1, viral protein VP1 and tubulin. (B) HeLa R19 cells were
infected with EMCV or ERAV at MOI 10 and lysed at indicated times post infection. Cell lysates were subjected to
Western Blot analysis for TBK1 and tubulin. (C) HeLa R19 cells were infected at MOI 10 with the indicated viruses
and lysed at 8 hpi. Cell lysates were subjected to Western Blot analysis for TBK1 and actin. (D) HeLa R19 cells were
infected with ERAV at MOI 10. Subsequently, the cells were incubated for 16h in the presence or absence of 10 μM
Q-VD, a pan-caspase inhibitor. Cell lysates were subjected to Western Blot analysis for TBK1, PARP and tubulin.
https://doi.org/10.1371/journal.ppat.1008702.g003
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of eIF4G appears to occur faster by Lpro L92A and L102A compared to wt Lpro, although a
more in-depth analysis is necessary to confirm a true difference in eIF4G cleavage kinetics.
Importantly, both mutations allow us to separate the deISGylase/DUB activity of Lpro from its
ability to cleave RLR signaling proteins. Serendipitously, we observed that Lpro carrying
Fig 4. Visualization and summary of the Lpro mutants used in this study. (A) Standard cartoon view of Lpro (grey)
bound to ISG15 (blue) (PDB: 6FFA). Lpro L92 and L102 interact with ISG15 W123, this positions ISG15’s C-terminus
(R153, L154 and G155) in the substrate binding cleft of Lpro. �In this structure a C-terminal propargyl warhead
replaced G155 [40]. Residues which upon mutation were reported to affect Lpro’s structure or function are shown as
colored sticks. Green: C51A inactivates Lpro’s catalytic activity; red: I83A or L86A reduce the DUB activity and IFN
induction; pink: L92A and L102A reduce affinity for ISG15; orange: C133S reduces affinity for eIF4G; aquamarine:
L143A predicted to open substrate binding pocket. Drawings were generated using PyMOL. (B) Overview of the
reported effects of the introduced mutations in Lpro on the various proteolytic activities of Lpro, this includes references
and the category of the underlying experimental evidence.
https://doi.org/10.1371/journal.ppat.1008702.g004
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mutation L143A was strongly impaired in degrading NF-κB p65 and cleaving MAVS and
TBK1, while cleavage of G3BP1 and eIF4G was delayed but could be observed clearly at later
timepoints (eIF4G cleavage is ~2 hr delayed, comparable to the delay observed for Lpro
C133S). Mutation of Lpro’s SAP domain (I83A/L86A), which was previously shown to abolish
Fig 5. Mutation of L143 or SAP domain strongly reduces cleavage and/or degradation of RLR signaling proteins. HeLa R19 cells were infected at
MOI 10 with the indicated viruses and lysed at 2, 4, 6, 8 h pi. Cell lysates were subjected to Western Blot analysis for MAVS, TBK1, NF-κB p65, IRF3,
eIF4G, G3BP1, Lpro, EMCV capsid proteins and tubulin.
https://doi.org/10.1371/journal.ppat.1008702.g005
Fig 6. Neither mutation of L92 or L102 affects the cleavage and/or degradation of RLR signaling proteins. HeLa
R19 cells were infected at MOI 10 with the indicated viruses and lysed at 2, 4, 6, 8 hpi. Cell lysates were subjected to
Western Blot analysis for MAVS, TBK1, NF-κB p65, IRF3, eIF4G, G3BP1, Lpro, EMCV capsid proteins and tubulin.
https://doi.org/10.1371/journal.ppat.1008702.g006
PLOS PATHOGENS Cleavage of RLR signaling proteins by FMDV Lpro correlates with type I IFN suppression
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008702 July 15, 2020 11 / 27
degradation of NF-κB p65 and DUB activity as well as to impair Lpro’s ability to reduce IFN-β
mRNA expression [36,39], also affected Lpro’s ability to cleave MAVS and TBK1. Overall, our
data demonstrate that the mutations have differential effects on the cleavage/degradation of
RLR signaling proteins. Importantly, we demonstrate that Lpro residues L92 and L102, which
are essential for its deISGylase/DUB activity, are not essential for is ability to cleave/degrade
RLR signaling proteins, indicating that the two different catalytic activities of Lpro can be
uncoupled.
Effect of Lpro mutations on DUB and deISGylase activities
It has been previously reported that mutations L92A, L102A and I83A/L96A affect Lpro’s deIS-
Gylase/DUB activity [39,40]. To determine the effect of mutations L143A or C133S on these
activities, mutant Lpro’s were expressed and purified from E. coli and in vitro catalytic activities
towards ubiquitin-TAMRA and ISG15-TAMRA were measured (Fig 7A). Lpro C133S and
L143A displayed wt-like activity towards ISG15 and ubiquitin. We next determined DUB
activity of wt Lpro, Lpro C51A, C133S and L143A in cells. To this end, we transfected HEK-
293T cells with a combination of HA-ubiquitin, FLAG-RIG-I and increasing amounts of
GFP-Lpro encoding plasmids (0.1, 0.3 and 0.5 μg), and visualized HA-tagged ubiquitinated
proteins by Western Blot analysis (Fig 7B). FLAG-RIG-I, which was included to monitor the
effects of Lpro-induced translational shut-off on the overexpressed proteins, was clearly detect-
able even at the highest level of Lpro (i.e. transfection of 0.5 μg of Lpro plasmid), indicating that
Fig 7. Mutation of L143 or C133S does not affect DUB or deISGylase activities. (A) Ubiquitin-TAMRA or
ISG15-TAMRA (substrates) were incubated with 10 μM or 100 nM Lpro (wt or indicated mutant), respectively. The
change in fluorescent polarization (mFP) was determined over 60 min, with readings recorded every 60 sec. The
average trace of assays performed in technical triplicate is shown. Substrate only and KG-TAMRA peptide served as
respective negative and positive controls. (B) HEK293T cells were transfected with 0.5 μg pcDNA-FLAG-RIG-I, 0.5 μg
pcDNA-HA-ubiquitin and 0.1–0.5 μg pIRES-GFP-Lpro. 16 h post transfection, cells were lysed and lysates subjected to
Western Blot analysis for FLAG, HA, GFP and tubulin.
https://doi.org/10.1371/journal.ppat.1008702.g007
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Lpro-induced translational shut-off did not significantly reduce the protein expression from
the transfected plasmids. Both wt Lpro as well as the C133S and L143A mutants displayed DUB
activity upon overexpression in cells, as indicated by the reduction of HA-tagged ubiquitinated
proteins upon increasing Lpro levels. Notably, we observed ubiquitinated proteins upon trans-
fection of low amount of Lpro C133S plasmid (0.1 μg), although our in vitro data (Fig 7A) indi-
cated that mutation C133S does not reduce the activity for ubiquitin. As the in vitro data are
much more quantitative in nature, we consider the relatively decreased DUB activity of Lpro
C133S in comparison to Lpro wt or mutant L143A as observed in Fig 7B the result of variations
in expression of the transfected plasmids.
Thus far, our data showed that mutations C133S and L143A did not affect Lpro’s DUB activ-
ity towards a mono-ubiquitin fused to a fluorescent TAMRA molecule. To exclude the possi-
bility that mutations C133S and L143A affect Lpro’s DUB activity towards other substrates, we
Fig 8. Mutation of L143 or C133 does not affect activity towards differently linked ubiquitin. Wild-type Lpro and
the Lpro mutants (C133S, L143A) were incubated with each of the eight di-ubiquitin chain types for the indicated
times, separated by SDS-PAGE, and visualized by silver-staining. The concentration of Lpro used in the cleavage assays
is indicated.
https://doi.org/10.1371/journal.ppat.1008702.g008
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determined its ability to cleave differently-linked di-ubiquitin molecules. Co-incubation of
Lpro with di-ubiquitin molecules of different linkages indicated that Lpro preferentially targets
K6- and K48-linked ubiquitin chains, displayed some activity towards K11-, K33-, K63-, and
M1-linked chains, but at this enzyme concentration and incubation times has no activity
towards K27- or K29-linked ubiquitin chains (Fig 8). Neither mutation L143A nor C133S
affected the ability of Lpro to cleave the di-ubiquitin molecules. Overall, our analysis shows that
Lpro carrying mutation L143A or C133S have wt-like deISGylase and DUB activity. Impor-
tantly, as mutation L143A impairs Lpro’s ability to cleave/degrade RLR signaling proteins (Fig
5), but does not affect its deISGylase/DUB activity, introduction of this mutation also allows us
to make a distinction between the two proteolytic activities of Lpro.
Lpro’s ability to reduce IFN-β mRNA levels correlates with its ability to
cleave/degrade RLR signaling proteins, not with its deISGylase/DUB
activity
Having characterized how the different mutations in Lpro affect its deISGylase/DUB activity or
the cleavage/degradation of RLR proteins, we next set out to determine which mutants reduce
the induction of IFN-β mRNA. We infected HeLa cells with EMCV, EMCV-LZn or the differ-
ent EMCV-Lpro mutants and determined the IFN-β mRNA and EMCV vRNA levels over time
via RT-qPCR analysis (Fig 9). Wildtype Lpro as well as Lpro C133S, L92A and L102A consis-
tently reduced the induction of IFN-β mRNA, while Lpro C51A and L143A were unable to do
so (Fig 9A). The SAP domain mutant (EMCV-Lpro I83A/L86A) also failed to suppress IFN-β
mRNA levels (Fig 9B), which is in agreement with observations in FMDV-infected cells
[36,39]. Notably, infection with EMCV Lpro L143A, which displayed wt deISGylase/DUB activ-
ity but is strongly impaired in its ability to cleave/degrade RLR signaling proteins MAVS,
TBK1 and NFκB p65, failed to suppress the induction of IFN-β mRNA. In contrast, Lpro L92A
and L102A,which are strongly impaired in their deISGylase/DUB activity [40] but not in their
ability to cleave/degrade RLR signaling proteins, reduced IFN-β mRNA levels. These com-
bined observations (summarized in Fig 10) demonstrate that cleavage/degradation of RLR sig-
naling proteins, but not the deISGylase/DUB activity of Lpro, correlate with suppressing IFN-
α/β gene transcription. Notably, Lpro C133S reduced the induction of IFN-β mRNA despite a
2h delay in eIF4G cleavage, indicating that the rapid eIF4G cleavage and the subsequent trans-
lational shut-off is not sufficient to suppress RLR signaling.
Discussion
FMDV suppresses IFN-α/β both at the mRNA and at the protein level [47], but the molecular
mechanism underlying the reduced induction of IFN-α/β gene transcription (RLR signaling)
is poorly understood. Both the DUB activity of Lpro as well as its ability to cleave/degrade RLR
signaling proteins have been implicated in the suppression of RLR signaling [35,37,39]. In this
study, we identified MAVS and TBK1 as novel Lpro substrates and mapped the cleavage site in
TBK1. Moreover, by introducing specific mutations we were able to separate Lpro’s deISGy-
lase/DUB activity from its ability to target RLR signaling proteins. Using Lpro carrying either
of these uncoupling mutations, we demonstrated that the cleavage/degradation of RLR signal-
ing proteins, not the deISGylase/DUB activity, correlates with the ability to reduce IFN-β gene
transcription. Collectively, our data strongly suggest that the ability of Lpro to cleave/degrade
RLR signaling proteins is needed to reduce the IFN-β mRNA levels.
We identified TBK1 as a new Lpro substrate and identified the cleavage site. We observed
cleavage of TBK1 both in HeLa cells infected with EMCV-Lpro and in FMDV-infected LFPK
cells, and we demonstrated that the Lpro cleavage site is located towards the C terminus of
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TBK1, more specifically in the coiled-coil 2 (CC2) domain. Previous work indicated that TBK1
ΔCC2 was signaling competent upon overexpression of TBK1. However, it was also shown
that mutation of residues L693 and K694, which are located in the CC2 domain, abolishes
IFN-β mRNA induction upon polyI:C transfection and VSV infection [50]. Lpro cleaves TBK1
at these residues. Yet, we observed that the N-terminal cleavage product restored RLR signal-
ing in TBK1 k.o. cells upon poly(I:C) stimulation. Whether this implies that the Lpro-mediated
cleavage of TBK1 does not contribute to the viral strategy to suppress RLR signaling and IFN-
β gene transcription remains unknown. Unfortunately, it is very difficult to investigate the
effect of TBK1 cleavage by Lpro on IFN-β gene transcription in infected cells, as Lpro also
cleaves other RLR signaling proteins, i.e. MAVS (this study) and LGP2 ([51], see below), and
the transcription factor NF-κB. Dissection of the effect of TBK1 cleavage on IFN-β gene tran-
scription from the effect of MAVS, LGP2 and NF-κB cleavage would require the identification
of all Lpro cleavage sites in these known targets followed by the generation of cells with cleav-
age-resistant versions of these proteins. It remains a question whether such an approach will
yield conclusive answers as other RLR signaling proteins may be targeted by Lpro, which have
Fig 9. Reduction in IFN-β gene transcription correlates with cleavage and/or degradation of RLR signaling
proteins. (A+B) Hela R19 cells were infected at MOI 10 with the indicated viruses and cells were lysed at 8 hpi. Total
RNA was isolated and used for RT-qPCR analysis for IFN-β and actin mRNA (upper panels), and EMCV vRNA (lower
panels). The IFN-β levels are depicted as a fold induction compared to levels in mock-infected cells, after correction for
actin mRNA levels. The EMCV vRNA is depicted as a copy number per cell, calculated from a plasmid standard. Error
bars represent the SD. One-way ANOVA with the Dunnet post hoc test was used to determine statistical significance
compared to the results for EMCV-LZn-infected cells (��, p<0.01; ���, p<0.001; ����, p<0.0001).
https://doi.org/10.1371/journal.ppat.1008702.g009
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not yet been identified. Hence, the relative importance of the Lpro-mediated cleavage of TBK1
for the viral suppression of IFN-β gene transcription remains unknown.
Fig 10. Overview of the effects of Lpro mutations on the different proteolytic activities of Lpro as well as reduction
in IFN-β gene transcription. (A) Standard cartoon view with transparent surface of Lpro bound to E69 inhibitor
shown as blue sticks (PDB: 4QBB). Residues which upon mutation were reported to affect Lpro’s structure or function
are shown as colored sticks. Green: C51A inactivates Lpro’s catalytic activity; red: I83A or L86A reduce the DUB
activity and IFN induction; pink: L92A and L102A reduce affinity for ISG15; orange: C133S reduces affinity for eIF4G;
aquamarine: L143A predicted to open substrate binding pocket. Drawings were generated using PyMol. (B) Overview
of the effects of introduced mutations on cleavage and/or degradation of host proteins, deISGylase/DUB activity, and
their ability to reduce IFN-β gene transcription. Coloring of mutations is consistent with panel A. The activities of the
mutations have been scored + +, +, + /–, or–according to the following criteria. + +, activity is similar to wt Lpro; +,
moderately reduced activity; + /–, severely impaired activity;–, no activity.
https://doi.org/10.1371/journal.ppat.1008702.g010
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Apart from its role in RLR signaling, TBK1 has been suggested to be involved in autophago-
some maturation. TBK1 was identified as a factor in the autophagosomal clearance of herpes
simplex virus 1 and mycobacteria [52,53]. A recent report showed that TBK1 phosphorylates
lipidated LC-3 to prevent premature removal of LC3 from autophagosomal membranes by
ATG4, thereby facilitating a unidirectional flow from the autophagosome to the lysosome [54].
Many picornaviruses hijack autophagic pathways to generate sites for viral RNA replication
and to facilitate non-lytic release of virions [55–61] Possibly, cleavage of TBK1 by Lpro facili-
tates the use of autophagy to aid viral infection and propagation.
Lpro also impacts MAVS integrity. A distinct MAVS cleavage product was observed upon
infection with EMCV-Lpro. Remarkably, no MAVS cleavage product was observed in FMDV-
infected cells, although MAVS levels progressively declined over time. The reason for this dif-
ference is unknown, but may be related to differences in human and porcine cells. Neverthe-
less, our data indicate that the integrity of MAVS is affected by Lpro in both cell types,
suggesting this RLR signaling protein is targeted by FMDV to affect IFN induction. Of note,
MAVS is known to localize to the peroxisomes and mitochondrion associated membranes of
the ER [62,63], in addition to its default localization on mitochondria. It remains to be estab-
lished whether Lpro targets all forms of MAVS or specifically targets MAVS at one of these
locations. TBK1 and MAVS are not the only RLR signaling proteins that are targeted by Lpro.
It was previously reported that overexpression of Lpro induces the degradation of IRF3 and
IRF7 [37], and that the p65 subunit of NF-κB is degraded in FMDV-infected cells [35]. We
also observed degradation of NF-κB p65 in EMCV-Lpro infected-cells but we did not observe
degradation of IRF3. Notably, degradation of IRF3 was also not observed in FMDV-infected
cells. Whether IRF3 degradation is restricted to certain cell types or conditions, or merely is an
artefact due to overexpression remains unknown.
It is remarkable that Lpro, comprising just 173 amino acids, can carry out several specific
proteolytic activities on both the viral and cellular substrates as summarized in Figs 4 and 10.
Previous work documented areas of the protease that are required for polyprotein processing
[41,49]. These residues included L143 which is part of the P2 pocket that can interact with leu-
cine residues in the substrate at the P2 position. In this work, L143 was identified as being
involved in TBK1 and MAVS cleavage; however, its replacement by alanine affected neither
the activity on eIF4G nor the deISGylase or DUB activities. Surprisingly, mutation of two resi-
dues of the SAP domain, (I83 and L86) also affected TBK1 and MAVS cleavage, even though
they are separated by 20 Å (measured between the respective Cα atoms) with helix α4 lying
between them. Nevertheless, it cannot be excluded that the SAP mutations cause some destabi-
lization of Lpro, thereby explaining this mutant’s defect in proteolytic activities. Further struc-
tural work will be required to understand how Lpro interacts with TBK1 and MAVS.
While this work was in progress, it was reported that LGP2, a factor that is essential for
MDA5 activation, is cleaved by Lpro [51]. The mutations in Lpro that impaired the reduction of
IFN-β mRNA levels (L143A and mutations in the SAP domain) displayed an overall defect in
the cleavage and/or degradation of each of the RLR signaling proteins we studied (i.e. MAVS,
TBK1 and NF-κB p65). We anticipate that the cleavage of LGP2 is also likely impaired by
introduction of these mutations. Our data suggest that expression of Lpro results in cleavage
and/or degradation of multiple RLR signaling proteins (MAVS, TBK1, NF-κB p65, and most
likely LGP2). The relative contribution of each cleavage event to the reduction in IFN-β gene
transcription remains unknown. A search for other substrates of Lpro is of importance to fur-
ther our understanding of the role and mechanism of how Lpro reduces IFN-α/β induction.
Possibly, such a search may identify RLR signaling proteins that are cleaved earlier than the
ones identified so far and may thereby have an influence on the early induction of type I IFN
in infected cells.
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The Lpro mutants that are defective in either the deISGylase/DUB activity or the cleavage/
degradation of RLR signaling proteins allowed us to study which ability is needed to suppress
RLR signaling. Mutation L143A, which rendered Lpro unable to reduce IFN-β mRNA levels,
impaired the cleavage of RLR signaling molecules, but had no effect on the deISGylase or DUB
activity of Lpro. Meanwhile, mutations L92A and L102A resulted in the opposite phenotypic
effect; RLR signaling proteins were cleaved with similar efficiency as wt Lpro, but the deISGylase
activity was significantly reduced by these mutations [40]. Yet, these Lpro mutants still reduced
IFN-β mRNA levels. Collectively, these data indicate that the activity of Lpro to cleave/degrade
RLR signaling proteins, not its deISGylase/DUB activity, is important for reduction of IFN-β
induction. Medina et. al. have just reported that impairment of the deISGylation activity of Lpro
causes viral attenuation in vitro and in vivo [64]. In support of our hypothesis, the mutations
introduced by Medina et. al. did not affect IFN or ISG mRNA expression levels [64].
It was previously suggested that the DUB activity of Lpro is important for the suppression of
RLR signaling [39], which contrasts our findings. Importantly, most experiments by Wang et.
al. relied on overexpression of Lpro, ubiquitin, and several targets proteins (i.e. RIG-I, TBK1,
TRAF3 and TRAF6). A recent study showed that Lpro should be predominantly regarded as a
deISGylase rather than a DUB, as biochemical evidence showed that Lpro has a 1000-fold
higher activity towards ISG15 than ubiquitin [40]. Given the weak DUB activity of Lpro in
vitro, it remains to be established whether Lpro genuinely acts as a DUB in FMDV-infected
cells under physiological conditions (i.e. without overexpression of components of the ubiqui-
tination system or known ubiquitination target proteins). Previously, we found no differences
in the levels of ubiquitinated proteins in cells infected with EMCV expressing wt Lpro or Lpro
C51A, whereas the levels of ISGylated protein were decreased in cells infected with EMCV-Lpro
[40], suggesting that Lpro predominantly acts as a deISGylase in infected cells.
It is well established that certain viruses (i.a. adenoviruses, herpesviruses and nidoviruses)
rely on viral proteases with DUB and deISGylase activity to suppress the induction of IFN-α/β
[9]. FMDV Lpro is a papain-like protease and thus Lpro is best compared to other virally
encoded papain-like cysteine proteases that suppress IFN-α/β gene transcription. Members of
the order Nidovirales (i.e. coronaviruses and arteriviruses) encode one or two papain-like cys-
teine protease (PLP), referred to as PLpro, or PLP1 and PLP2 when the virus encodes two PLPs.
In addition to cleaving the viral polyprotein, PLpro and the equivalent PLP2 have acquired
DUB and deISGylase activity [65–73]. Structure-guided mutagenesis of PLpro of MERS-CoV
and PLP2 of equine arterivirus (EAV) allowed the DUB activity to be separated from the pro-
teolytic activity portrayed towards the viral polyprotein [72,73]. This uncoupling of these two
different proteolytic activities indicated that the DUB activity of PLpro/PLP2 contributes to the
suppression of IFN-α/β transcription [72,73]. Unfortunately, it has not been determined
whether PLpro/PLP2 cleaves RLR signaling proteins and thus it is unclear what other proteo-
lytic activities could be affected by the mutations that were introduced. Notably, the cleavage
site of nidovirus PLpro/PLP2 and FMDV Lpro in ubiquitin and ISG15 is different. While
SARS-CoV PLpro breaks the iso-peptide bond between ubiquitin or ISG15 and the target pro-
tein [65,66], FMDV Lpro is a non-canonical deISGylase that targets a peptide bond in ISG15
itself, resulting in a diglycylated-lysine in the target protein [40]. In conclusion, nidovirus
PLpro/PLP2 and FDMV Lpro are both papain-like proteases, but they likely have evolved differ-
ent strategies to suppress IFN-α/β gene transcription.
FMDV Lpro and enterovirus 2Apro are structurally different enzymes that share many func-
tions; both cleave translation initiation factor eIF4G [34,74,75], both reduce IFN-α/β gene
transcription [27,47,76,77], both have been implicated in the suppression of SG formation
[77–79] and both have been suggested to rescue viral translation from the inhibitory effects of
p-eIF2 [80,81]. Importantly, Lpro and 2Apro both cleave several RLR signaling proteins, but the
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only overlapping RLR protein is MAVS [27,76]. Although a causal relationship between cleav-
age of RLR proteins and suppression of IFN-α/β transcription remains to be established for
both proteases, the convergence on the cleavage of MAVS is noteworthy. In the absence of
sequence homology, no evolutionary basis for the functional similarities between the two
picornavirus proteases can be determined. Possibly, the extensive similarities between FMDV
Lpro and enterovirus 2Apro, both picornavirus proteases, is illustrative of the urgency for picor-
naviruses to suppress these particular antiviral host responses.
Our data suggests that the deISGylase activity of Lpro is not critically needed to suppress
RLR signaling, but rather its role should be sought in the broader antiviral activities of ISG15
(reviewed in [10,11]). It should be noted that our experiments were performed in naïve cells at
high multiplicity of infection. Expression of the ISGylation machinery as well as ISG15 itself
are boosted by IFN-α/β and therefore we cannot formally exclude a role for the DUB and/or
deISGylase activity of Lpro in suppressing RLR signaling under different conditions (e.g. in
IFN-primed cells). ISG15 has many functions, both intracellular and extracellular. Intracellular
ISG15 can act both pro-inflammatory and immunomodulatory, either via ISGylation of target
proteins or as free ISG15. Moreover, ISG15 can be secreted to act as a cytokine [25,26]. ISG15
also plays a role in damage repair after clearing viral infection [82] and can regulate cellular
processes such as autophagy and metabolism [24,83–85]. How the deISGylase activity of Lpro
contributes to efficient in vivo infection, remains to be established.
Materials and methods
Cells and viruses
HeLa R19, HeLa R19 TBK1 k.o. and Hek293T cells were maintained in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 10% FCS (V/V). HeLa OHIO cells were main-
tained in DMEM supplemented with 10% FCS (V/V) and 1% penicillin/streptomycin. LFPK
αvβ6 cells [86] were obtained from the Foreign Animal Disease Diagnostic Laboratory
(FADDL) at the PIADC. These cells were maintained in minimal essential medium (MEM)
supplemented with 10% FCS (V/V) and 1% antibiotics and non-essential amino acids. BHK-
21 cells used for FMDV propagation were maintained in MEM supplemented with 10% FCS
(V/V), 10% tryptose phosphate broth, 1% antibiotics and non-essential amino acids. HeLa R19
TBK1 k.o. cells were generated via CRISPR/cas9 methodology using a pCRISPR plasmid, as
described previously [87]. The used gRNA sequences are 5’-GCTACTGCAAATGTCTTTCG-
3’ and 5’-GAGGAAAACAGATTGGTT-3’. FMDV A12-WT (wild type) was generated from
the full-length serotype A12 infectious clone, pRMC35 [88] and A12-LLV2 (leaderless virus)
was derived from the infectious clone lacking the Lb coding region, pRM-LLV2 [89]. Viruses
were propagated in BHK-21 and concentrated by polyethylene glycol precipitation, titrated on
BHK-21 cells, and stored at -70˚C. ERAV (NM-11/67 strain) (gift from D. Rowlands and T.
Tuthill [90]) was obtained after passage on HeLa R19 cells and subsequently concentrated by
ultracentrifugation through a 30% sucrose cushion at 140,000xg for 16 hours in a SW32Ti
rotor and stored at -80˚C. Recombinant EMCVs were generated by cloning the genes of inter-
est into the XhoI/NotI restriction sites from the pM16.1-VFETQG-Zn infectious clone that
was described previously [45]. EMCV-Lpro viruses were recovered by transfection of run-off
RNA transcripts into BHK-21 cells. Upon total CPE, viruses were concentrated by ultracentri-
fugation (as described for ERAV) and stored at -80˚C.
Antibodies
The following antibodies were used for Western blot staining procedures: αFMDV VP1 (rabbit
polyclonal Abmade at PIADC), αEMCV capsid (gift from Ann Palmenberg), αLpro (gift from
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Ewald Beck and Tim Skern), αMAVS (Enzo life science ALX-210-929), αTBK1 (Cell signaling
3504), αIRF3 (Santa cruz sc-9082), αNF-κB-p65/RelA (Santa Cruz Biotechnology SC-8008),
αeIF4G (Bethyl laboratories A300-502A), αG3BP1 (BD biosciences clone 23/G3BP), αPARP
(Roche Diagnostics #11835238001), αFLAG (Sigma M2), αGFP (Invitrogen OSE00003G),
αHis (GE Healthcare, 27-4710-01), αMyc (Clone 4A6, Millipore), αHA (Abcam ab130275)
and αtubulin (Sigma DM1A). Respective IRdye680 or IRdye800 conjugated secondary anti-
bodies (LiCOR) or HRP-conjugated secondary antibodies were used for detection.
RT-PCR analysis
HeLa R19 cells were seeded in 24-wells plates and the next day infected with the indicated
viruses at MOI 10 or transfected with the indicated plasmids or vRNA. Plasmids were trans-
fected using Fugene6 (Promega) and vRNA was transfected using Lipofectamine 2000 (Invi-
trogen), both according to the manufacturer’s instructions. Preparation of viral dsRNA and
the pcDNA-GFP-MAVS construct have been described previously [1,44]. pEGFP-IRF3 [D5]
construct was a kind gift from John Hiscott [91]. At the indicated time points cells were lysed
and cellular RNA was isolated using total RNA isolation kit (Machery-Nagel) according to
manufacturer’s instructions. Reverse transcription was set up using TaqMan Reverse Tran-
scription Reagents (Applied Biosystems) before performing qPCR analysis with SYBR green
(Roche) as described previously [92].
Western Blot analysis of transfected cells
The pIRES-EGFP-FMDV Lpro plasmid was described previously [45]. The pcDNA-FLAG-
TBK1 plasmid was a gift from John Hiscott [93] and the pEF-FLAG-RIG-I was a gift from
Takashi Fujita [94]. HA-ubiquitin was expressed from a pCMV5 plasmid. Hek293T cells were
seeded in 6-well plates and the next day transfected with 1.5 μg of total plasmid using Fugene6
(Promega) according to manufacturer’s instructions. 16h posttransfection cells were lysed
100 μl lysisbuffer (100 mM Tris pH 8.0, 1 mM EDTA, 50 mM NaCl, 1% NP40, protease inhibi-
tor mix (Roche)). Post nuclear lysate was obtained by centrifugation at 15000xg at 4˚C for 15
min. The amount of total protein in the lysates was determined using BCA assay (Thermo-
Fisher) and 100 μg of protein was resolved using reducing sodiumdodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) and transferred to 0.2 μm nitrocellulose membranes
by wet electrophoretic transfer. Membranes were incubated 1h in blocking buffer (PBS + 0.1%
Tween 20 + 2% BSA) and successively incubated overnight with primary antibodies diluted in
blocking buffer and then for 30 min with respective secondary antibodies diluted in blocking
buffer. Between and after the incubations, the membranes were washed three times with PBS
+0.1% Tween-20. Finally, membranes were washed once with PBS and scanned using an
Odyssey Imager (Li-COR).
Western Blot analysis of infected cells
HeLa R19 cells were seeded in 10 cm dishes and infected the next day with the indicated
viruses at MOI 10. At the indicated time points cells were released using trypsin, washed once
in PBS and lysed in 100 μl lysis buffer (100 mM Tris pH 8.0, 1 mM EDTA, 50 mM NaCl, 1%
NP40, protease inhibitor mix (Roche)). Subsequent steps are identical as described for trans-
fected cells. For the analysis of FMDV-infected LFBK αvβ6 cultures, cells were lysed in lysis
buffer (0.5% NP-40 substitute, 50mM Tris pH 7.5, 150mM NaCl, 1mM EDTA). Lysates were
incubated at 4˚C for 10 min and cellular debris was collected by centrifugation at 10,000xg for
15 min at 4˚C. 40 ng of protein was resolved by SDS-PAGE, transferred by Western blot and
secondary antibodies conjugated with horseradish peroxidase (Pierce) were used for detection
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of proteins. Following incubation with appropriate primary and secondary antibodies, protein
bands were visualized using SuperSignal West Dura Extended Duration Substrate (Thermo-
Scientific, Rockford, IL, USA) according to the manufacturer’s directions.
In vitro TBK1 cleavage
sLpro was expressed and purified as reported previously [95]. 275 ng of His-hTBK1 (Millipore)
was incubated with 0–3 μg sLpro for 2 h at 30˚C in a HEPES buffer (20 mM HEPES pH 7.4, 150
mM KCl, 1 mM EDTA) before the reaction mixture was dissolved on SDS-PAGE. Proteins
were transferred to nitrocellulose and Western blot staining for the his-tag was performed.
Myc-mTBK1 and Myc-mTBK1692AAA694 were transiently expressed in HeLa OHIO cells from
plasmid pCS2-6Myc-mTBK1, a gift from T. Decker. 20 μg myc-tagged mTBK1 containing cell
lysate was incubated with 2 μg sLpro for 2 h at 30˚C in a HEPES buffer before resolving the
reaction mixture on SDS-PAGE, transferring the protein to nitrocellulose membrane and per-
forming Western blot staining for Myc.
In vitro DUB and deISGylase assays
Ubiquitin/ISG15-TAMRA assays were performed according to [96]. Di-ubiquitin in vitro
cleavage assays were performed as described previously [97].
Supporting information
S1 Fig. N-terminal TBK1 cleavage fragment can facilitate RLR signaling. (A) HeLa R19
TBK1 k.o. cells were generated using CRISPR/cas9 technology. Wt and TBK1 k.o. cells were
lysed and lysates subjected to Western Blot analysis for TBK1 and tubulin. (B) IFN-β induction
upon various triggers of RLR signaling was compared in wt and TBK1 k.o. cells. Cells were
infected with EMCV-LZn virus at MOI 10, transfected with 20 ng vRNA, or transfected with
1 μg of plasmid expressing MAVS or IRF3. Cells were lysed at 8 h pi or transfection. Total
RNA was isolated and used for RT-qPCR analysis for IFN-β and actin mRNA. The IFN-β lev-
els are depicted as a fold induction compared to levels in mock-treated cells, after correction
for actin mRNA levels. Error bars depict the SD. (C) HeLa R19 TBK1 k.o. cells were trans-
fected with 2 μg plasmid expressing full-length or truncated TBK1 (TBK1 Δ35aa). TBK1 Δ35aa
is representative for the Lpro-generated N-terminal cleavage product. Cells were lysed and
lysates subjected to Western Blot analysis for TBK1 and tubulin. (D) TBK1 k.o. cells were
reconstituted with full-length TBK1 as described for (C) and subsequently transfected with
100 ng poly(I:C). Cells were lysed at 8 h post transfection of poly(I:C). Total RNA was isolated
and used for RT-qPCR analysis for IFN-β and actin mRNA. The IFN-β levels are depicted as a
fold induction compared to levels in mock-treated cells, after correction for actin mRNA lev-
els. Error bars depict the SD. (E) TBK1 k.o. cells were reconstituted with full-length or trun-
cated TBK1 (TBK1 Δ35aa) as described for (C). Subsequent steps as described for (D). Error
bars depict the SD.
(TIF)
Acknowledgments
We are grateful to John Hiscott and Takashi Fujita for supplying plasmids, Ann Palmenberg
and Ewald Beck for providing antibodies, and David Rowlands and Toby Tuthill for supplying
ERAV.
PLOS PATHOGENS Cleavage of RLR signaling proteins by FMDV Lpro correlates with type I IFN suppression
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008702 July 15, 2020 21 / 27
Author Contributions
Conceptualization: Linda J. Visser, Raoul J. de Groot, Martijn A. Langereis, Tim Skern, Frank
J. M. van Kuppeveld.
Data curation: Linda J. Visser, Chiara Aloise, Kirby N. Swatek, Gisselle N. Medina, Karin M.
Olek, Huib H. Rabouw.
Formal analysis: Linda J. Visser, Chiara Aloise, Kirby N. Swatek, Gisselle N. Medina,
Karin M. Olek, Huib H. Rabouw.
Funding acquisition: Linda J. Visser, Martijn A. Langereis, Teresa de los Santos, David
Komander, Tim Skern, Frank J. M. van Kuppeveld.
Investigation: Linda J. Visser, Chiara Aloise, Kirby N. Swatek, Gisselle N. Medina, Karin M.
Olek, Huib H. Rabouw.
Methodology: Linda J. Visser, Martijn A. Langereis, Frank J. M. van Kuppeveld.
Project administration: Linda J. Visser, Frank J. M. van Kuppeveld.
Supervision: Raoul J. de Groot, Martijn A. Langereis, Teresa de los Santos, David Komander,
Tim Skern, Frank J. M. van Kuppeveld.
Validation: Linda J. Visser, Kirby N. Swatek, Gisselle N. Medina, Karin M. Olek, Raoul J. de
Groot, Martijn A. Langereis, Teresa de los Santos, David Komander, Tim Skern, Frank J.
M. van Kuppeveld.
Visualization: Linda J. Visser, Chiara Aloise, Kirby N. Swatek, Gisselle N. Medina, Karin M.
Olek, Frank J. M. van Kuppeveld.
Writing – original draft: Linda J. Visser, Tim Skern, Frank J. M. van Kuppeveld.
Writing – review & editing: Linda J. Visser, Kirby N. Swatek, Gisselle N. Medina, Karin M.
Olek, Huib H. Rabouw, Raoul J. de Groot, Martijn A. Langereis, Teresa de los Santos,
David Komander.
References
1. Feng Q, Hato SV V., Langereis MAA, Zoll J, Virgen-Slane R, Peisley A, et al. MDA5 Detects the Dou-
ble-Stranded RNA Replicative Form in Picornavirus-Infected Cells. Cell Rep. 2012; 2: 1187–1196.
https://doi.org/10.1016/j.celrep.2012.10.005 PMID: 23142662
2. Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW. MDA5 and MAVS mediate
type I interferon responses to coxsackie B virus. J Virol. 2010; 84: 254–60. https://doi.org/10.1128/JVI.
00631-09 PMID: 19846534
3. Kuo R-L, Kao L-T, Lin S-J, Wang RY-L, Shih S-R. MDA5 Plays a Crucial Role in Enterovirus 71 RNA-
Mediated IRF3 Activation. Jin D-Y, editor. PLoS One. 2013; 8: e63431. https://doi.org/10.1371/journal.
pone.0063431 PMID: 23650567
4. Hüsser L, Alves MP, Ruggli N, Summerfield A. Identification of the role of RIG-I, MDA-5 and TLR3 in
sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res.
2011; 159: 9–16. https://doi.org/10.1016/j.virusres.2011.04.005 PMID: 21539869
5. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014; 14: 36–49.
https://doi.org/10.1038/nri3581 PMID: 24362405
6. Goubau D, Deddouche S, Reis e Sousa C. Cytosolic Sensing of Viruses. Immunity. 2013; 38: 855–869.
https://doi.org/10.1016/j.immuni.2013.05.007 PMID: 23706667
7. Chiang C, Gack MU. Post-translational Control of Intracellular Pathogen Sensing Pathways. Trends
Immunol. 2017; 38: 39–52. https://doi.org/10.1016/j.it.2016.10.008 PMID: 27863906
8. Heaton SM, Borg NA, Dixit VM. Ubiquitin in the activation and attenuation of innate antiviral immunity. J
Exp Med. 2016; 213: 1–13. https://doi.org/10.1084/jem.20151531 PMID: 26712804
PLOS PATHOGENS Cleavage of RLR signaling proteins by FMDV Lpro correlates with type I IFN suppression
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008702 July 15, 2020 22 / 27
9. Bailey-Elkin BA, Knaap RCM, Kikkert M, Mark BL. Structure and Function of Viral Deubiquitinating
Enzymes. J Mol Biol. 2017; 429: 3441–3470. https://doi.org/10.1016/j.jmb.2017.06.010 PMID:
28625850
10. Perng Y-C, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018; 16: 423–
439. https://doi.org/10.1038/s41579-018-0020-5 PMID: 29769653
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